AI assistant
Borosil Limited — Investor Presentation 2021
Aug 16, 2021
59157_rns_2021-08-16_bc8532d5-19c9-437c-a1ae-935c9d8c1802.pdf
Investor Presentation
Open in viewerOpens in your device viewer

August 16, 2021
| The DCS - CRD | |
|---|---|
| BSE Limited | National Stock Exchange of India Ltd |
| Corporate Relationship Department | Exchange Plaza, C-1, Block G, |
| st Floor, New Trading Ring,1 | Bandra Kurla Complex, |
| Rotunda Building, P. J. Towers, | Bandra (East), |
| Dalal Street, | Mumbai – 400 051 |
| Mumbai – 400 001 | |
Dear Sir / Madam,
Scrip Code: 543212 Symbol: BOROLTD Series: EQ ISIN: INE02PY01013
Sub: Presentation on Company's performance for the quarter ended June 30, 2021
Enclosed please find the Presentation on Company's performance for the quarter ended June 30, 2021.
You are requested to take the same on record.
Thanking you.
Yours faithfully, For Borosil Limited
Manoj Dere Company Secretary & Compliance Officer Membership No. FCS 7652
Encl: as above
Borosil Investor presentation - Q1FY22 01

Borosil Limited - Investor Presentation Q1FY22
"This investor presentation has been prepared by Borosil Limited ("Borosil" or "Company") on a strictly

Safe harbour statement
Market Leader-Microwavable Kitchenware in India (Consumer Products)
Market Leader-Laboratory Glassware

Brand with a 50+year legacy years of

About Borosil



To be the most customer-centric company in India

Re-Imagining Consumer

Borosil Investor presentation - Q1FY22 05
Glass Products Company
Occasional Use (Microwavable)
Single Brand
General Trade




Lab Glassware only
Domestic Business

Single Brand BOROSIL






Financial Overview Q1FY22(consolidated)
| Q1FY21 | Q1FY22 | Growth % | |
|---|---|---|---|
| Net Sales | 56.10 | 137.88 | 145.8% |
| EBITDA | (1.53) | 19.42 | 1367.7% |
| EBITDA(Before one-time items) | 2.08 | 25.45 | 1125.4% |
| PBT | (10.53) | 10.70 | 201.7% |
| PAT | (7.36) | (1.90) | 74.2% |
| Net Cash (Period end) | 94.74 | 245.57 |

Category wise sales (Consumerware)




| Category | Q1 FY21 | Q1FY22 | Growth % |
|---|---|---|---|
| Glassware | 8.36 | 22.39 | 167.9% |
| Non Glassware | 7.24 | 28.95 | 299.8% |
| Opalware | 4.08 | 32.40 | 693.2% |
| Total Consumerware | 19.68 | 83.73 | 325.4% |

Category wise sales (Scientific)


INR Crore
| Category | Q1FY21 | Q1FY22 | Growth % |
|---|---|---|---|
| Laboratory Glassware | 20.24 | 28.18 | 39.2% |
| Lab Instrumentation | 2.45 | 4.24 | 72.9% |
| Pharma Packaging | 13.73 | 21.74 | 58.4% |
| Total Scientific | 36.41 | 54.15 | 48.7% |


(consolidated business)

| Q1FY21 | Q1FY22 | |
|---|---|---|
| Advertising & SalesPromotion (ASP) | 1.8% | 4.5% |
| Personnel Costs | 34.9% | 16.3% |
| EBITDA Margin(before one-time items) | 0.8% | 15.2% |
| EBITDA Margin beforeASP & one time items | 2.6% | 19.8% |
% of Net Revenue


Capital Employed (Standalone)



| Consumerware | Scientific | Borosil | |||||
|---|---|---|---|---|---|---|---|
| FY20 | FY21 | FY20 | FY21 | FY20 | FY21 | ||
| Working CapitalEmployed | 115 | 58 | 56 | 44 | 170 | 102 | |
| Working Capital(Days of Sales) | 97 | 55 | 130 | 113 | 105 | 71 | |
| Operating CapitalEmployed | 311 | 223 | 142 | 103 | 453 | 327 | |
| Goodwill * | 59 | 59 | |||||
| Strategic Investments ** | 67 | 67 | |||||
| Net Surplus Funds | 75 | 247 | |||||
| Total Capital Employed | 311 | 223 | 142 | 103 | 654 | 700 | |
| Goodwill created due to the Composite Scheme of Amalgamation and Arrangement.* Strategic Investments are investment in subsidiaries namely Klasspack, Borosil Technologies and Acalypha.The Company expects returns on these strategic investments in the coming years. |







Consumer Division





needs of a modern kitchen
• Contemporary • • Everyday Use • • • • •

Consumer Products

- Glass Microwaveables
- Tumblers
- Storage
- Opalware
- Domestic Appliances

| 100 | 10% |
|---|---|
| 440 | 10% |
| 15% to 20% | |
| 500 | 20% |
| 15% | |
| 9000 | 10% |

Note : Market size, growth & share are internal estimates
Borosil - Ally of Progressive Homemaker

hi tea, Travel, Workout


Trade Partners












Some Key Institutional Customers



















Growth Pillars



Larah Opal Dinner Ware Category gaining salience

Larah FY21 revenue INR 141.05 cr
No 2 player in a high growth category
Large opportunity in Opal dinner ware
- Microwaveable, Light, Strong, Chip resist
- Ideal for mass market daily use
- Introducing customisable options
Margin Improvement initiatives for the medium term
- New Fulfilment Centre to optimize truck utilization (implemented)
- Packaging rationalization
- Product mix and measured price increases
- Operating leverage with scale on advertising & fixed overheads


Storage Range Thoughtful Products creating a new pillar of growth


- Very low penetration of glass storage
Awareness of Glass as a superior option on the rise
High grade steel designs for on-the-go products like flasks & hot food cases an opportunity
Indian kitchen storage dominated by plastic and steel
-
No health hazard as in some types of plastic
-
Transparent as against opaque steel & plastic getting stained and translucent over time
-
Looks as good as new for extended period of time
-
Good design ensures stack-ability & space optimization

Consumer Products -Medium-Term Thrust Areas
| Achie- Increase- Introdu |
|---|
| $-$ Gain sh- Accelera |
| BecorMaintai- IntroduBenchm |
| Impro- Improve- Rationa- Control |
| Optim- Better eIncreas |
Ive Revenue CAGR of 20%
e penetration of glass storage and Opalware Ice high quality & innovative To-Go storage products are in premium niche domestic appliances ate Growth in E-Commerce
me Brand of Consumer Choice
- in investments in brand building
- ace new and improved range of products
- nark Online consumer experience with Best in Class
ove EBITDA Margins
- re logistics costs alize packaging costs
- Fixed Overheads
nize Capital Employed
estimation of channel inventories Increase share of domestic sourcing





Scientific Products


Scientific Products Range





Pharma packaging
- Glass vials
- Glass ampoules
| Lab Glassware India | Lab GlasswareExports | LabInstrumentation | Pharma Packaging(Vials & Ampoules) | |
|---|---|---|---|---|
| Market Size (INR Cr) | 235 | 4000 | 150 | 235 |
| Est. Market Growth | ~8-10% | ~0-2% | ~8-10% | ~10-12% |
| Customers | Pharma R&D & QC,Government Labs,Food & Soil Testing,EducationalInstitutes | Pharma R&D & QC | Pharma R&D & QC,Government Labs,Food & Soil Testing,EducationalInstitutes | Pharma cos |
| Brand | Borosil | Borosil | LabQuest byBorosil | Klasspack |

Scientific Products -Some key Customers

RANBAXY

TIMylan® Seeingis believing








Scientific Products Portfolio Growth Pillars


International expansion for lab glassware
Focus on Middle East, Africa, South East Asia, USA
Seed market and build new client relationships. Leverage India cost arbitrage
Scientific Products: Medium-Term Thrust Areas

Achieve Revenue CAGR of 10%
- Maintain dominant share in pharma lab glassware
- New customers in Food Testing
- Drive import substitution in Lab instrumentation increase product range
- Add new customers for vials & ampoules
Maintain EBITDA Margins
- Manage changing portfolio composition
Cash Flow Efficiency
- Manage inventories with scale

Laboratory Glassware
Borosil Investor presentation - Q1FY22 29
Meeting wide product range need of customer -

-
- Single supplier convenient for laboratory for multiple critical yet low ticket SKUs -
-
Not easily replicable by competition
Quick & on-time delivery of SKU range
-
Investment in inventory, 6 warehouses & dealer network
-
Well managed Inventory more than offsets loss of sale
Products meet international quality benchmarks
Strong customer relationships
- Low propensity of customer to switch


Primary Packaging for Pharma
- Glass Ampoules & Tubular Glass Vials for packaging pharmaceutical products
- Complements Borosil's analytical vials range (used in the lab)
- Provides Borosil's Pharmaceutical Customers credible 2nd alternative for their packaging needs
- more entrants
- COVID 19 opening many market opportunities

Borosil Limited Key Enablers & Capabilities

- Single supplier convenient for laboratory for multiple critical yet low ticket SKUs
Strong steady Scientific business to support growth
Established network of happy channel partners
Strong Balance Sheet with cash surplus
- Acquisitions to supplement organic growth

Board of Directors

Pradeep Kumar Kheruka Chairman

Anupa Rajeev Sahney Independent Director


Shreevar Kheruka Vice Chairman and Managing Director & CEO

Whole Time Director
Kewal Kundanlal Handa Independent Director

Kanwar Bir Singh Anand Independent Director

Rajesh Kumar Chaudhary

Naveen Kumar Kshatriya Independent Director
Equity information
No of issued shares of Re 1 each: 11,41,19,467
Shareholding Pattern:

0.2% Other institutions
- 70.5% Promoters
Bloomberg Ticke
NSE Ticker:
BSE Ticker:
Market Capitaliz as on - 30 Jun 2

| er : | 1369812D:IN |
|---|---|
| BOROLTD | |
| 543212 | |
| zation021 : | INR 2498 Cr |

-
1101, Crescenzo,G-Block,
-
Opposite MCA Club, Bandra Kurla Complex
-
Bandra (East), Mumbai 400 051.
Investor Relations:


Thank you
borosil.com myborosil.com
